Neck Cancer

Oncology

44 drugs in development·16 companies·1 clinical trial

Drug Pipeline by Phase

Approved(2)

Drug	Company
Erbitux	ELI LILLY & Co (LLY)
Erbitux®	ELI LILLY & Co (LLY)

Phase 3(3)

Drug	Company
AXAL (axalimogene filolisbac / ADXS-HPV)	Ayala Pharmaceuticals, Inc. (ADXS)
cetuximab	Incyte Corp. (INCY)
Xevinapant	Merck & Co., Inc. (MRK)

Phase 2(5)

Drug	Company
eseba-vec	HOOKIPA Pharma Inc. (HOOK)
fs118	F-star Therapeutics, Inc. (FSTX)
hb-200	HOOKIPA Pharma Inc. (HOOK)
lsta1	LISATA THERAPEUTICS, INC. (LSTA)
sgx942	SCICLONE PHARMACEUTICALS INC (SCLN)

Phase 1(29)

Drug	Company
CUE-101	Cue Biopharma, Inc. (CUE)
tsc-200-a0201	TScan Therapeutics, Inc. (TCRX)
tsc-200-a0201 + tsc-201-b0702	TScan Therapeutics, Inc. (TCRX)
tsc-200-a0201 + tsc-202-a0201	TScan Therapeutics, Inc. (TCRX)
tsc-200-a0201 + tsc-203-a0201	TScan Therapeutics, Inc. (TCRX)
tsc-200-a0201 + tsc-204-a0101	TScan Therapeutics, Inc. (TCRX)
tsc-201-b0702	TScan Therapeutics, Inc. (TCRX)
tsc-201-b0702 + tsc-202-a0201	TScan Therapeutics, Inc. (TCRX)
tsc-202-a0201	TScan Therapeutics, Inc. (TCRX)
tsc-203-a0201	TScan Therapeutics, Inc. (TCRX)
tsc-203-a0201 + tsc-201-b0702	TScan Therapeutics, Inc. (TCRX)
tsc-203-a0201 + tsc-202-a0201	TScan Therapeutics, Inc. (TCRX)
tsc-203-a0201 + tsc-204-a0101	TScan Therapeutics, Inc. (TCRX)
tsc-204-a0101	TScan Therapeutics, Inc. (TCRX)
tsc-204-a0101 + tsc-202-a0201	TScan Therapeutics, Inc. (TCRX)
tsc-204-a0201	TScan Therapeutics, Inc. (TCRX)
tsc-204-a0201 + tsc-200-a0201	TScan Therapeutics, Inc. (TCRX)
tsc-204-a0201 + tsc-201-b0702	TScan Therapeutics, Inc. (TCRX)
tsc-204-a0201 + tsc-202-a0201	TScan Therapeutics, Inc. (TCRX)
tsc-204-a0201 + tsc-203-a0201	TScan Therapeutics, Inc. (TCRX)
tsc-204-a0201 + tsc-204-a0101	TScan Therapeutics, Inc. (TCRX)
tsc-204-a0201 + tsc-204-c0702	TScan Therapeutics, Inc. (TCRX)
tsc-204-c0702	TScan Therapeutics, Inc. (TCRX)
tsc-204-c0702 + tsc-200-a0201	TScan Therapeutics, Inc. (TCRX)
tsc-204-c0702 + tsc-201-b0702	TScan Therapeutics, Inc. (TCRX)
tsc-204-c0702 + tsc-202-a0201	TScan Therapeutics, Inc. (TCRX)
tsc-204-c0702 + tsc-203-a0201	TScan Therapeutics, Inc. (TCRX)
tsc-204-c0702 + tsc-204-a0101	TScan Therapeutics, Inc. (TCRX)
uza-cel	Adaptimmune Therapeutics PLC (ADAP)

Preclinical(4)

Drug	Company
apvo455	Aptevo Therapeutics Inc. (APVO)
gtb-5550	GT Biopharma, Inc. (GTBP)
theralink pan-tumor assay 1.0	THERALINK TECHNOLOGIES, INC. (THER)
VPS4A inhibitors (novel series)	Calithera Biosciences, Inc. (CALA)

Phase 1/Phase 2(1)

Drug	Company
tqb2922	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)

Compare drugs

Erbitux vs AXAL (axalimogene filolisbac / ADXS-HPV)Erbitux vs cetuximab Erbitux vs Xevinapant

Frequently asked questions

How many drugs are in development for Neck Cancer?

BioSniper tracks 44 drugs in development for Neck Cancer across 16 companies.

How many clinical trials target Neck Cancer?

There are 1 clinical trial targeting Neck Cancer tracked by BioSniper.

Deep-dive into Neck Cancer

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis